International Journal of Medical and All Body Health Research  |  e-ISSN: 2582-8940  |  Double-Blind Peer Review  |  Open Access  |  CC BY-NC-SA 4.0

Current Issues
     2026:7/4

International Journal of Medical and All Body Health Research

e-ISSN: 2582-8940 | Open Access

Formulation and evaluation of metoprolol tartrate transdermal drug patches

Article Information

Volume / Issue5 / 2 (June-December 2024)
Pages22-25
AccessOpen Access

Publication Timeline

  • Received05 March 2024
  • Accepted07 April 2024

Full Text (PDF)

Open Access - Free to Download

Download Full Article (PDF) JATS XML

Abstract

The objective of present study was to develop matrix type transdermal therapeutic systems of Metoprolol tartrate using various such as Sodium alginate and HPMC polymers as matrix formers. Results revealed that prepared patches showed good physical characteristics and no drug-polymer interaction was observed. The in vitro release study revealed that F3 formulation showed maximum release in 8 hrs. Formulation F3 was subjected for accelerated stability studies. The F3 formulation was found to be stable as there was no drastic change in the Physico-chemical properties of the patches, which was also confirmed by FTIR. Thus, conclusion can be made that stable transdermal patch of Metoprolol tartrate has been developed. F3 formulation showed highest cumulative percentage drug release of 93.97 % were obtained during in vitro drug release studies after 8 hrs. The predominant release mechanism of drug through the fabricated matrices was believed to be by diffusion mechanism. Based upon the in vitro dissolution data the F3 formulation was concluded as optimized formulation. 

References

  1. Asbill CS, Michniak BB. Percutaneous penetration enhancers: Local versus transdermal activity. Pharm Sci Technolo Today. 2000; 3:36–41. [Google Scholar][Crossref]
  2. Balaji P, Thirumal M, Gowri R, Divya V, Ramaswamy V. Design and evaluation of matrix type of transdermal patches of methotrexate. Int J Pharm Chem Biol Sci. 2012; 2:464–71. [Google Scholar][Crossref]
  3. Ashok Kumar. Transdermal drug delivery system: an overview. Int J Pharm Sci Rev Res. 2010 Jul-Aug; 3(2)009. [Google Scholar][Crossref]
  4. Mounika B. Transdermal drug delivery system with formulation and evaluation aspects: Overview. Res J Pharm Technol. 2012; 5(9):1168-1176. [Google Scholar][Crossref]
  5. Venkateshwara Reddy B. Formulation and evaluation of carvedilol transdermal patches with hydrophilic polymers. World J Pharm Res. 2014; 3(10):815-826. [Google Scholar][Crossref]
  6. Shasikanth. Formulation and evaluation of transdermal drug delivery system of carvedilol. J Pharm Res. 2009. [Google Scholar][Crossref]
  7. Gannu. Development of carvedilol transdermal patches: evaluation of physicochemical, in vivo and mechanical properties. PDA J Pharm Sci Technol. 2008 Nov-Dec; 62(6):391-401. [Google Scholar][Crossref]
  8. Megha N. Design and evaluation of carvedilol transdermal patch using natural polymers. J Pharm Res. 2012; 5(10):4947-4949. [Google Scholar][Crossref]
  9. Dinesh Babu. Design and evaluation of valsartan transdermal patches. Int J Res Ayurveda Pharm. 2012 May; 3(3):461-464. [Google Scholar][Crossref]
  10. Kashinatha BP. Design and evaluation of transdermal film of valsartan by using modified polymer. J Pharm Res. 2012; 5(5):2823-2829. [Google Scholar][Crossref]
  11. Ekapol. Preparation and evaluation of diltiazem hydrochloride diffusion-controlled transdermal delivery system. AAPS PharmSciTech. 2008 Jun; 9(2):464–470. [Google Scholar][Crossref]
  12. Jeevanandham S. Formulation and evaluation of dual transdermal patch containing metformin hydrochloride -metoprolol tartarate. Int J Adv Pharm. 2014; 4(3):160-164. [Google Scholar][Crossref]
  13. Gaikwad AK. Transdermal drug delivery system: Formulation aspects and evaluation- A Review. Compr J Pharm Sci. 2013; 1(1):1-10. [Google Scholar][Crossref]
  14. Selvam RP, Singh AK, Sivakumar T. Transdermal drug delivery systems for antihypertensive drugs - A review. Int J Pharm Biomed Res. 2010; 1(1):1-8. Copyright and License © The Author(s). Authors retain the copyright of their published articles. This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution Non Commercial-Share A like 4.0 International (CC BY-NC-SA 4.0) License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. [Google Scholar][Crossref]

How to Cite

Anitha, M. R., Karthik, T., Vaishnavi, K., Manogna, K., & Vhishnavi, M. (2024). Formulation and evaluation of metoprolol tartrate transdermal drug patches. International Journal of Medical and All Body Health Research, 5(2), 22-25.

Anitha, Mary Rathna, et al. "Formulation and evaluation of metoprolol tartrate transdermal drug patches." International Journal of Medical and All Body Health Research, vol. 5, no. 2, 2024, pp. 22-25.

Anitha, M. R., Karthik, T., Vaishnavi, K., Manogna, K. and Vhishnavi, M. (2024) 'Formulation and evaluation of metoprolol tartrate transdermal drug patches', International Journal of Medical and All Body Health Research, 5(2), pp. 22-25.

Anitha MR, Karthik T, Vaishnavi K, Manogna K, Vhishnavi M. Formulation and evaluation of metoprolol tartrate transdermal drug patches. International Journal of Medical and All Body Health Research. 2024;5(2):22-25.

Share

Find this Article on

Google Scholar Semantic Scholar OpenAlex ResearchGate BASE

A newly published article may take a few days to appear on these services.